Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial

Administration of pegylated granulocyte-colony-stimulating factor (peg-GCSF) 24 to 72 hours after chemotherapy is usually recommended. Next-day administration (after 24 hours) resulted in fewer duration of grade (Gr) 4 chemotherapy-induced neutropenia (CIN) and decreased severity of CIN than same-da...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kwonoh, Jeon, Young-Kyung, Kim, Jung Hoon, Choi, Younak, Kim, Jae-Joon, Oh, Sang-Bo, Oh, So Yeon, Hong, Yun Jeong, Huh, Seok Jae, Kim, Ilhwan, Shin, Seong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194448/
https://www.ncbi.nlm.nih.gov/pubmed/37335745
http://dx.doi.org/10.1097/MD.0000000000033638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194448/
https://www.ncbi.nlm.nih.gov/pubmed/37335745
http://dx.doi.org/10.1097/MD.0000000000033638

Ejemplares similares